Early Evaluation of the Food and Drug Administration (FDA) Adverse Event Monitoring System (AEMS): An Analysis of Over 32 Million Pharmacovigilance Reports. [PDF]
Lakhan SE.
europepmc +1 more source
A pharmacovigilance study of sirolimus-associated adverse events in organ transplantation. [PDF]
Yi DZ +6 more
europepmc +1 more source
A retrospective analysis of gastrointestinal adverse events associated with nicorandil using the FDA Adverse Event Reporting System (FAERS) following STROBE guidelines. [PDF]
Chen C, Long D, Lei Y, Yang L, Zhang R.
europepmc +1 more source
Adverse event of ACE inhibitors: A descriptive analysis of FAERS data. [PDF]
Ahmed NJ.
europepmc +1 more source
Hematological toxicities in bevacizumab associated with ovarian cancer: A pharmacovigilance study using FDA adverse event reporting system database. [PDF]
Zhou X +6 more
europepmc +1 more source
A Comprehensive Disproportionality Analysis of Drug-Related Head Injury Reports Using the FAERS Database. [PDF]
Guo J +5 more
europepmc +1 more source
Safety evaluation of subcutaneous and intravenous administration of infliximab: a real-world study based on the FAERS database. [PDF]
Zheng X +5 more
europepmc +1 more source
Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence. [PDF]
Li X +5 more
europepmc +1 more source
Medication-related nephrotic syndrome: a real-world study from 2004 to 2024 based on the Food and Drug Administration Adverse Event Reporting System. [PDF]
Zheng Y, Han T, Wu Y, Wang T, Wang J.
europepmc +1 more source
Thrombocytopenia and anemia associated with piperacillin-tazobactam: integrating clinical case series with FAERS disproportionality analysis. [PDF]
Lu J +5 more
europepmc +1 more source

